The Inhibition of Bruton Tyrosine Kinase Alleviates Acute Liver Failure via Downregulation of NLRP3 Inflammasome.
Bingjue YeShiwei ChenHuiting GuoWeiyang ZhengGuohua LouXue LiangYanning LiuCheng ZhouMin ZhengPublished in: Journal of immunology (Baltimore, Md. : 1950) (2022)
There is no effective treatment for acute liver failure (ALF) except for an artificial liver support system (ALSS) and liver transplant. Bruton tyrosine kinase (Btk) plays important immunoregulatory roles in the inflammatory diseases, but its possible function in ALF remains to be characterized. In this study, we detected the phosphorylation level of Btk in ALF mouse liver and analyzed the protective effects of Btk inhibitor on survival rate and liver damage in ALF mouse models. We measured the expression levels of various inflammatory cytokines in the ALF mouse liver and primary human monocytes. In addition, we examined the expression of the NLRP3 inflammasome in mouse models with or without Btk inhibition. Clinically, we observed the dynamic changes of Btk expression in PBMCs of ALSS-treated patients. Our results showed that Btk was upregulated significantly in the experimental ALF mouse models and that Btk inhibition alleviated liver injury and reduced the mortality in these models. The protective effect of Btk inhibitors on ALF mice partially depended on the suppression of NLRP3 inflammasome signaling. Clinical investigations revealed that the dynamic changes of Btk expression in PBMCs could predict the effect of ALSS treatment. Our work shows that Btk inhibition is an effective therapeutic strategy for ALF. Moreover, Btk is a useful indicator to predict the therapeutic effect of ALSS on liver failure, which might have great value in clinical practice.
Keyphrases
- tyrosine kinase
- liver failure
- nlrp inflammasome
- epidermal growth factor receptor
- hepatitis b virus
- poor prognosis
- mouse model
- liver injury
- drug induced
- clinical practice
- endothelial cells
- binding protein
- oxidative stress
- type diabetes
- signaling pathway
- cell proliferation
- ejection fraction
- cardiovascular disease
- long non coding rna
- cardiovascular events
- adipose tissue
- skeletal muscle
- high fat diet induced
- replacement therapy